DSM to exclusively market lactose-analyzing device

27 Feb 2018

DSM has announced that it will exclusively market BIOMILK 300, a compact residual lactose-analyzing device produced by BIOLAN, as from February 2018.

DSM to exclusively market lactose-analyzing device

DSM has announced that it will exclusively market BIOMILK 300, a compact residual lactose-analyzing device produced by BIOLAN, as from February 2018. For dairy producers, the BIOMILK 300 is said to be a fast, cost-effective, and accurate analyzer for quantifying residual lactose levels in lactose-free and lactose-reduced dairy products.

Consumers are, the company notes, increasingly aware of the health appeal of lactose-free dairy, which is driving rapid growth for this segment. To keep pace with this growth, DSM believes it is crucial for lactose-free dairy producers to have an accurate and fast measurement of the residual lactose-level at every moment in their process, resulting in shorter lead times.

DSM says it recognized the need among its customers for fast, reliable measurement of residual lactose levels that is also cost-effective. As a result, DSM has partnered with BIOLAN, who design and manufacture analytical solutions based on biosensor technology, to bring BIOMILK 300 to a larger proportion of the global dairy industry.

“DSM is very pleased to partner with BIOLAN to bring this remarkable technology to a wider use within the dairy industry,” said Merel Roes, Global Business Line Manager Dairy Enzymes at DSM. “BIOLAN’s expertise with biosensor technology, together with DSM’s strong history as a leading lactase producer and partner in the dairy industry, allows us to meet the growing needs of manufacturers of lactose-free dairy products even better than before.”

The BIOMILK 300 is said to offer several benefits, including having a fast analysis time of less than 3 minutes, being cost-effective and accurate with a high sensitivity that can detect and quantify residual lactose levels at less than 0.01%. It is also said to be easy to use, requiring no extensive lab skills to operate or any additional equipment to read the results.

The BIOMILK 300 is recommended for use with Maxilact, DSM’s lactase range. With Maxilact, DSM says that dairy producers can produce lactose-free dairy products that taste great while achieving lactose levels in products that are lower than 0.01%—the future standard in the industry.